• PRINT EDITIONS
  • | CONTACT
  • | TEL: 540.962.2121 | E: hello@virginianreview.com
Tuesday, November 17, 2026
The Virginian Review
  • NEWS
    • NEWS CENTER
    • CRIME
    • COMMUNITY
    • LOCAL NEWS
    • STATE NEWS
    • NATIONAL NEWS
    • BUSINESS & TECH
  • Obituaries
  • GOVERNMENT
    • GOVERNMENT NEWS CENTER
    • CITY
    • COUNTY
    • STATE
  • Sports
    • SPORTS CENTER
    • LOCAL SPORTS
    • HIGH SCHOOL SPORTS
    • COLLEGE SPORTS
  • Entertainment
  • Public Notices
    • LEGAL NOTICES
    • PUBLIC ANNOUNCEMENTS
    • STATEWIDE LEGAL SEARCH
  • The Shadow
No Result
View All Result
  • NEWS
    • NEWS CENTER
    • CRIME
    • COMMUNITY
    • LOCAL NEWS
    • STATE NEWS
    • NATIONAL NEWS
    • BUSINESS & TECH
  • Obituaries
  • GOVERNMENT
    • GOVERNMENT NEWS CENTER
    • CITY
    • COUNTY
    • STATE
  • Sports
    • SPORTS CENTER
    • LOCAL SPORTS
    • HIGH SCHOOL SPORTS
    • COLLEGE SPORTS
  • Entertainment
  • Public Notices
    • LEGAL NOTICES
    • PUBLIC ANNOUNCEMENTS
    • STATEWIDE LEGAL SEARCH
  • The Shadow
No Result
View All Result
The Virginian Review
No Result
View All Result
Photo: Liberty University

Liberty To Take On No. 8 Tennessee In First Round of NCAA Championship

November 17, 2026
Photo: JMU Athletics 

Regular-Season Finale Set For Saturday

November 17, 2026

Virginia Residents To Receive Nationwide Emergency Alert System Test Today

November 17, 2026
No. 10 Virginia (11-4-4) is a two seed in the 2026 NCAA Women’s Soccer Tournament and will host Bryant (7-6-5) in  a first-round matchup at 3 p.m. on Friday (Nov. 20) at Klöckner Stadium. Photo: UVA Athletics 

Virginia To Host Bryant In NCAA First-Round Matchup Friday

November 17, 2026
Tech advances to its 15th NCAA Tournament appearance. Photo: VT Athletics 

Hokies Punch Ticket To NCAA Tournament, Will Travel To Face Kentucky

November 17, 2026

Tags

Alleghany Alleghany County Bath County Business Cat Clifton Clifton Forge Community County Covington Dear Abby District Echoes of the Past Education Family Featured Forge Game Health Home Individual Information Law Meeting Nation Night Obituary Office OK Parent Past People Rent Report Road School Street Student Team Time Tree VA Virginia War West
QR Code

Weight Loss Drug Now Available In U.S.

by The Virginian Review
in News
March 20, 2021
Reading Time: 3 mins read
0
5
SHARES
30
VIEWS
Share on FacebookShare on TwitterEMAIL

WASHINGTON (AP) – Arena Pharmaceuticals says its weight loss drug Belviq will be available to U.S. patients this week, nearly a year after the drug was officially approved by federal regulators.

The Food and Drug Administration approved Belviq last June for adults who are obese or who are overweight and have at least one serious medical condition, such as diabetes or high cholesterol. At the time, Belviq was the first new drug approved by the FDA for long-term weight loss in more than a decade.

Despite only achieving modest weight loss in clinical studies, the drug was safe enough to win the FDA’s endorsement, amid calls from doctors for new weight-loss treatments.

The drug’s launch was delayed for months by logistical hurdles, including classification by the Drug Enforcement Administration. According to the drug’s label, Belviq will be classified as a Schedule IV controlled substance, which means it has a low potential for abuse. A small segment of patients in company studies reported experiencing euphoria and hallucinations.

Arena Pharmaceuticals and partner Eisai Co. said Friday the drug will be available beginning today. Under an agreement between the companies, Arena will manufacture and supply the drug from its facility in Switzerland and Eisai will market the drug in the U.S.

Because of the delays to its launch, Belviq actually arrives on the market 10 months after competitor Vivus’ Qsymia, which launched in September. Studies have shown that Qsymia produces more weight loss than Belviq.

Patients taking Qsymia for a year lost 6.7 percent of their body weight in one study and 8.9 percent in another study.

Arena’s studies showed that patients taking Belviq, known generically as lorcaserin, lost just 3 percent to 3.7 percent of their weight over a year. About 47 percent of patients without diabetes lost at least 5 percent of their weight or more, which was enough to meet FDA standards for effectiveness.

The FDA said patients should stop taking Belviq after three months if they fail to lose 5 percent of their body weight.

Patients are unlikely to see any significant weight loss by staying on the drug, the agency said.

Side effects with the drug include depression, migraine and memory lapses.

Belviq is designed to stimulate serotonin receptors in the brain linked with feelings of satiety, leading patients to feel full.

The drug will face an uphill battle in the U.S. market for weight loss treatments. Analysts have generally been disappointed with Qsymia sales, despite that drug’s superior results.

Qsymia sales have fallen short in part because of limited insurance coverage and high out-of-pocket expenses for patients with coverage.

Qsymia also has only been available through mail order, but Vivus said last month the FDA will allow some retail pharmacy distribution. The company expects to announce more on that in the third quarter.

Vivus said batches from the initial production of Qsymia had a shelf life of 24 months, and the company is applying to the Food and Drug Administration to extend that to 36 months for current and future production.

This page is available to subscribers. Click here to sign in or get access.

The Virginian Review

The Virginian Review has been serving Covington, Clifton Forge, Alleghany County and Bath County since 1914.

Related Posts

National News

Virginia Residents To Receive Nationwide Emergency Alert System Test Today

November 17, 2026
News

Alleghany Highlands Public Schools November Meeting Live Stream

November 16, 2026
News

Alleghany Highlands Weather

November 15, 2026
News

Staunton District Traffic Alert for Nov. 16–20, 2026

November 15, 2026
Load More
Next Post

Alleghany County Circuit Court

The Virginian Review

Serving Covington, Clifton Forge, Alleghany County and Bath County Since 1914.

Information

  • Privacy Policy
  • Terms & Conditions
  • Ethics, Standards & Corrections
  • Careers
  • Contact Us

© 2022 The Virginian Review | All Rights Reserved. | Powered by Ecent Corporation

No Result
View All Result
  • Menu Item
  • __________________
  • Home
  • Editions
  • News
    • Community
    • Government
  • Obituaries
  • Sports
  • Public Notices
    • Public Announcements
  • The Shadow
  • __________________
  • Contact Us
  • Careers
  • Subscribe
  • Terms & Conditions
  • Privacy Policy

© 2022 The Virginian Review | All Rights Reserved. | Powered by Ecent Corporation

Published on June 11, 2013 and Last Updated on March 20, 2021 by The Virginian Review